Published in Cardiovasc Res on January 29, 2010
Heart regeneration. Nature (2011) 5.91
Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation (2011) 2.29
Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26
Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells (2010) 2.10
Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. JACC Heart Fail (2014) 1.76
Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential. PLoS One (2015) 1.40
Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials (2012) 1.14
Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors. Mol Biol Rep (2011) 1.10
Preconditioning stem cells for in vivo delivery. Biores Open Access (2014) 1.09
Challenges for heart disease stem cell therapy. Vasc Health Risk Manag (2012) 1.02
HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation. Fibrogenesis Tissue Repair (2014) 1.00
Secreted proteins as a fundamental source for biomarker discovery. Proteomics (2012) 0.98
Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network. Mol Ther (2011) 0.97
Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond) (2013) 0.95
Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway. PLoS One (2012) 0.90
Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? Stem Cell Res Ther (2013) 0.90
Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab. Stem Cells Transl Med (2012) 0.89
Human embryonic stem cell-derived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a. Stem Cells Dev (2013) 0.87
Cardiosphere-derived cell sheet primed with hypoxia improves left ventricular function of chronically infarcted heart. Am J Transl Res (2015) 0.86
Isolation, Characterization, and Spatial Distribution of Cardiac Progenitor Cells in the Sheep Heart. J Clin Exp Cardiolog (2012) 0.86
Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research. Heart Fail Rev (2014) 0.83
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure. Int J Mol Sci (2015) 0.82
Cardiac progenitor cell sheet regenerates myocardium and renews hope for translation. Cardiovasc Res (2010) 0.80
Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transition. PLoS One (2012) 0.80
Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology. Annu Rev Physiol (2015) 0.80
Human cardiosphere-derived cells from patients with chronic ischaemic heart disease can be routinely expanded from atrial but not epicardial ventricular biopsies. J Cardiovasc Transl Res (2012) 0.79
Autologous preconditioned mesenchymal stem cell sheets improve left ventricular function in a rabbit old myocardial infarction model. Am J Transl Res (2016) 0.79
Advances in cell transplantation therapy for diseased myocardium. Stem Cells Int (2011) 0.78
Endogenous cardiac stem cells for the treatment of heart failure. Stem Cells Cloning (2013) 0.78
Chronic heart failure is associated with transforming growth factor beta-dependent yield and functional decline in atrial explant-derived c-Kit+ cells. J Am Heart Assoc (2013) 0.78
Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum. Stem Cell Res Ther (2013) 0.78
Diastolic ventricular support with cardiac support devices: an alternative approach to prevent adverse ventricular remodeling. Heart Fail Rev (2013) 0.78
Effects of scaffold material used in cardiovascular surgery on mesenchymal stem cells and cardiac progenitor cells. Ann Thorac Surg (2014) 0.77
Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? Ann Palliat Med (2012) 0.77
Impact of cardiac stem cell sheet transplantation on myocardial infarction. Surg Today (2013) 0.76
Multipotent stem cells of the heart-do they have therapeutic promise? Front Physiol (2015) 0.76
Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells. J Clin Med (2014) 0.75
Neurovascular Cell Sheet Transplantation in a Canine Model of Intracranial Hemorrhage. Cell Med (2016) 0.75
CXCR4 expression is associated with time-course permanent and temporary myocardial infarction in rats. Iran J Basic Med Sci (2017) 0.75
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 10.27
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 9.44
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood (2002) 9.40
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet (2003) 6.85
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med (2006) 4.53
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64
CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res (2005) 3.03
Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation (2002) 2.84
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation (2003) 2.82
Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol (2008) 2.60
Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation (2006) 2.17
Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation (2008) 1.95
Differentiation and migration of Sca1+/CD31- cardiac side population cells in a murine myocardial ischemic model. Int J Cardiol (2009) 1.70
Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant (2003) 1.66
Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A (2009) 1.42
Myocardial tissue engineering. Br Med Bull (2008) 1.17
Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg (2000) 1.08
Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction. Cell Transplant (2009) 1.05
Cell therapy for myocardial infarction: Special delivery. J Mol Cell Cardiol (2007) 0.99
Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J Heart Lung Transplant (2006) 0.99
Persistence of marrow stromal cells implanted into acutely infarcted myocardium: observations in a xenotransplant model. J Thorac Cardiovasc Surg (2005) 0.96
Current state of the art in myocardial tissue engineering. Tissue Eng (2007) 0.94
Lapine and canine bone marrow stromal cells contain smooth muscle actin and contract a collagen-glycosaminoglycan matrix. Tissue Eng (2001) 0.87
Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery (2006) 0.86
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Coronary-artery revascularization before elective major vascular surgery. N Engl J Med (2004) 7.80
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A (2008) 2.59
Astrocytic complexity distinguishes the human brain. Trends Neurosci (2006) 2.26
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics (2008) 2.11
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation (2003) 2.03
Research leadership and investigators: gender distribution in the federal government. Am J Med (2012) 1.98
Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol (2003) 1.91
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics (2006) 1.88
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes (2009) 1.83
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv (2011) 1.66
Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol (2007) 1.60
Initial results of wireless pressure sensing for endovascular aneurysm repair: the APEX Trial--Acute Pressure Measurement to Confirm Aneurysm Sac EXclusion. J Vasc Surg (2007) 1.59
Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med (2009) 1.55
Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. Neurobiol Aging (2005) 1.51
Perioperative complications after vascular surgery are predicted by the revised cardiac risk index but are not reduced in high-risk subsets with preoperative revascularization. Circ Cardiovasc Qual Outcomes (2009) 1.48
Hormone replacement therapy is associated with improved survival in women with advanced heart failure. J Am Coll Cardiol (2003) 1.48
Preoperative coronary artery revascularization and long-term outcomes following abdominal aortic vascular surgery in patients with abnormal myocardial perfusion scans: a subgroup analysis of the coronary artery revascularization prophylaxis trial. Catheter Cardiovasc Interv (2011) 1.45
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation (2002) 1.42
Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging (2013) 1.37
Ethics: Moral issues of human-non-human primate neural grafting. Science (2005) 1.35
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med (2004) 1.33
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation (2005) 1.32
The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications (2011) 1.29
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging (2005) 1.24
Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging (2008) 1.24
Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta. Aging Cell (2010) 1.22
Percutaneous closure of aortic pseudoaneurysm by Amplatzer occluder device-case series of six patients. Catheter Cardiovasc Interv (2009) 1.19
Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J Mol Cell Cardiol (2004) 1.11
One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv (2009) 1.08
Transhepatic approach to closure of patent foramen ovale: report of 2 cases in adults. Tex Heart Inst J (2010) 1.06
Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction. Cell Transplant (2009) 1.05
The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther (2007) 1.03
Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol Aging (2008) 1.00
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid (2002) 1.00
Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J Heart Lung Transplant (2006) 0.99
The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation. Pacing Clin Electrophysiol (2010) 0.98
Comparison of frequency of coronary artery calcium in healthy Hispanic versus non-Hispanic white men by electron beam computed tomography. Am J Cardiol (2003) 0.97
Angiotensin subtype 1 rReceptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther (2003) 0.95
Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease. J Comp Neurol (2009) 0.94
Myocardial cytokine IL-8 and nitric oxide synthase activity during and after resuscitation: preliminary observations in regards to post-resuscitation myocardial dysfunction. Resuscitation (2008) 0.92
Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production. J Card Fail (2006) 0.92
Augmented therapeutic efficacy of an oncolytic herpes simplex virus type 1 mutant expressing ICP34.5 under the transcriptional control of musashi1 promoter in the treatment of malignant glioma. Hum Gene Ther (2007) 0.90
Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy. J Gene Med (2006) 0.88
Ventricular remodeling in heart failure. J Card Fail (2002) 0.88
Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure. Cardiology (2002) 0.87
Ventricular fibrillation waveform characteristics are different in ischemic heart failure compared with structurally normal hearts. Resuscitation (2006) 0.87
Utility of nuclear stress imaging for detecting coronary artery bypass graft disease. BMC Cardiovasc Disord (2012) 0.86
Viable fibroblast matrix patch induces angiogenesis and increases myocardial blood flow in heart failure after myocardial infarction. Tissue Eng Part A (2010) 0.86
Costs and quality of life associated with radial artery and saphenous vein cardiac bypass surgery: results from a Veterans Affairs multisite trial. Am J Surg (2011) 0.86
Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med (2011) 0.86
Unusual combination of holt-oram syndrome and persistent left superior vena cava. Congenit Heart Dis (2011) 0.85
Failure of benefit and early hazard of bucindolol for Class IV heart failure. J Card Fail (2003) 0.85
Microglial responses to amyloid beta peptide opsonization and indomethacin treatment. J Neuroinflammation (2005) 0.85
Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant (2005) 0.83
Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg (2006) 0.83
BACE1 levels are elevated in congestive heart failure. Neurosci Lett (2012) 0.82
Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction. Am J Physiol Heart Circ Physiol (2002) 0.82
Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. Int J Mol Epidemiol Genet (2009) 0.81
The effects of poloxamer-188 on left ventricular function in chronic heart failure after myocardial infarction. J Cardiovasc Pharmacol (2012) 0.81
Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol (2007) 0.81
Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transition. PLoS One (2012) 0.80
Successful coronary angiography with adequate image acquisition using a combination of gadolinium and a power injector in a patient with severe iodine contrast allergy. Exp Clin Cardiol (2012) 0.80
Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. JACC Cardiovasc Interv (2010) 0.80
Stem cell therapy in ischemic heart disease. Cardiovasc Drug Rev (2003) 0.79
Pretreatment with angiotensin receptor blockade prevents left ventricular dysfunction and blunts left ventricular remodeling associated with acute myocardial infarction. Circulation (2006) 0.79
Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: the impact of stents, adjunctive pharmacology, and multicomponent distal protection. Catheter Cardiovasc Interv (2006) 0.79
Coronary sinus diverticulum complicating CRT device implantation. Pacing Clin Electrophysiol (2008) 0.79
Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarction. J Cardiovasc Pharmacol (2004) 0.79
A comprehensive cardiac rehabilitation program in post-CABG patients: a rationale and critical pathway. Crit Pathw Cardiol (2003) 0.78
Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril. J Cardiovasc Pharmacol (2007) 0.78
Modified thrombolytic therapy for massive pulmonary emboli. Am J Med (2011) 0.78
Translational potential of thyroid hormone and its analogs. J Mol Cell Cardiol (2011) 0.78
Chronic heart failure is associated with transforming growth factor beta-dependent yield and functional decline in atrial explant-derived c-Kit+ cells. J Am Heart Assoc (2013) 0.78
Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc Diabetol (2003) 0.78
Effects of BG9928, an adenosine A₁ receptor antagonist, in patients with congestive heart failure. J Clin Pharmacol (2010) 0.77
Disparate opinions regarding indications for coronary artery revascularization before elective vascular surgery. Am J Cardiol (2004) 0.77
Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cells. Curr Vasc Pharmacol (2007) 0.77
Thoracic endografting is a viable option for the octogenarian. Ann Thorac Surg (2010) 0.76
Immune tolerance and stroke: a turning point. Stroke (2002) 0.76
Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation. J Cardiovasc Pharmacol (2007) 0.76
Noncardiac chest pain: the role of the cardiologist--a national survey. J Clin Gastroenterol (2005) 0.76
The generalizability of participants in Veterans Affairs Cooperative Studies Program 474, a multi-site randomized cardiac bypass surgery trial. Contemp Clin Trials (2010) 0.76
The epigenetics of Alzheimer's disease--additional considerations. Neurobiol Aging (2011) 0.75
Clenbuterol plus granulocyte colony-stimulating factor regulates stem/progenitor cell mobilization and exerts beneficial effect by increasing neovascularization in rats with heart failure. J Card Fail (2013) 0.75
The reply. Am J Med (2013) 0.75
Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention. Catheter Cardiovasc Interv (2005) 0.75
Shocks from pacemaker cardioverter defibrillators increase with amiodarone in patients at high risk for sudden cardiac death. Cardiology (2003) 0.75
In vivo Electrophysiological Study of Induced Ventricular Tachycardia in Intact Rat Model of Chronic Ischemic Heart Failure. IEEE Trans Biomed Eng (2016) 0.75
Consequences of radial artery harvest: results of a prospective, randomized, multicenter trial. JAMA Surg (2013) 0.75
Critical pathway for cardiac rehabilitation after percutaneous coronary intervention. Crit Pathw Cardiol (2003) 0.75